Biologics in rheumatoid arthritis - recommendations for Swiss practice.
Détails
Etat: Public
Version: Final published version
ID Serval
serval:BIB_1626948634BD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Biologics in rheumatoid arthritis - recommendations for Swiss practice.
Périodique
Swiss Medical Weekly
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
2011
Volume
141
Pages
w13189
Langue
anglais
Résumé
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland.
Mots-clé
rheumatoid arthritis, biologics, anti-TNF, treatment optimisation, guidelines, CONTROLLED-TRIAL, DOUBLE-BLIND, COMBINATION THERAPY, METHOTREXATE, MULTICENTER, OUTCOMES, AGENT, ETANERCEPT, INHIBITION, RITUXIMAB
Pubmed
Web of science
Open Access
Oui
Création de la notice
08/06/2011 11:10
Dernière modification de la notice
20/08/2019 13:45
Données d'usage
